Edwards Lifesciences Net Income 2010-2024 | EW

Edwards Lifesciences annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Edwards Lifesciences net income for the quarter ending March 31, 2024 was $0.352B, a 3.35% increase year-over-year.
  • Edwards Lifesciences net income for the twelve months ending March 31, 2024 was $1.414B, a 5.04% decline year-over-year.
  • Edwards Lifesciences annual net income for 2023 was $1.402B, a 7.85% decline from 2022.
  • Edwards Lifesciences annual net income for 2022 was $1.522B, a 1.25% increase from 2021.
  • Edwards Lifesciences annual net income for 2021 was $1.503B, a 82.55% increase from 2020.
Edwards Lifesciences Annual Net Income
(Millions of US $)
2023 $1,402
2022 $1,522
2021 $1,503
2020 $823
2019 $1,047
2018 $722
2017 $584
2016 $570
2015 $495
2014 $811
2013 $389
2012 $292
2011 $237
2010 $218
2009 $229
Edwards Lifesciences Quarterly Net Income
(Millions of US $)
2024-03-31 $352
2023-12-31 $370
2023-09-30 $385
2023-06-30 $307
2023-03-31 $341
2022-12-31 $398
2022-09-30 $344
2022-06-30 $406
2022-03-31 $374
2021-12-31 $335
2021-09-30 $340
2021-06-30 $490
2021-03-31 $338
2020-12-31 $310
2020-09-30 $325
2020-06-30 $-122
2020-03-31 $311
2019-12-31 $280
2019-09-30 $275
2019-06-30 $242
2019-03-31 $250
2018-12-31 $7
2018-09-30 $226
2018-06-30 $283
2018-03-31 $207
2017-12-31 $-3
2017-09-30 $170
2017-06-30 $186
2017-03-31 $230
2016-12-31 $159
2016-09-30 $141
2016-06-30 $127
2016-03-31 $143
2015-12-31 $141
2015-09-30 $118
2015-06-30 $113
2015-03-31 $123
2014-12-31 $109
2014-09-30 $95
2014-06-30 $547
2014-03-31 $60
2013-12-31 $75
2013-09-30 $77
2013-06-30 $93
2013-03-31 $144
2012-12-31 $89
2012-09-30 $69
2012-06-30 $68
2012-03-31 $65
2011-12-31 $63
2011-09-30 $52
2011-06-30 $58
2011-03-31 $64
2010-12-31 $65
2010-09-30 $48
2010-06-30 $58
2010-03-31 $48
2009-12-31 $48
2009-09-30 $74
2009-06-30 $48
2009-03-31 $61
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $52.348B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.815B 26.27
Intuitive Surgical (ISRG) United States $152.521B 91.88
DexCom (DXCM) United States $46.342B 70.20
Alcon (ALC) Switzerland $43.615B 31.25
IDEXX Laboratories (IDXX) United States $41.651B 48.82
IQVIA Holdings (IQV) United States $38.867B 22.55
STERIS (STE) Ireland $21.364B 24.96
SONOVA HOLDING (SONVY) Switzerland $18.279B 0.00
Waters (WAT) United States $17.455B 25.65
Hologic (HOLX) United States $16.670B 18.65
Fresenius Medical Care AG KGaA (FMS) Germany $11.719B 13.68
Sysmex ADR (SSMXY) Japan $10.095B 31.66
Teleflex (TFX) United States $9.692B 15.09
Globus Medical (GMED) United States $9.027B 26.46
Penumbra (PEN) United States $7.261B 82.52
Masimo (MASI) United States $7.185B 41.39
Glaukos (GKOS) United States $5.641B 0.00
TransMedics (TMDX) United States $4.713B 447.11
Integer Holdings (ITGR) United States $3.930B 23.75
PROCEPT BioRobotics (PRCT) United States $3.190B 0.00
LivaNova (LIVN) United Kingdom $2.867B 17.03
Tandem Diabetes Care (TNDM) United States $2.777B 0.00
Nihon Kohden (NHNKY) Japan $2.650B 14.04
Inari Medical (NARI) United States $2.513B 0.00
Elekta AB (EKTAY) Sweden $2.397B 18.38
Integra LifeSciences Holdings (IART) United States $2.277B 9.93
RxSight (RXST) United States $2.075B 0.00
Veracyte (VCYT) United States $1.634B 0.00
Alphatec Holdings (ATEC) United States $1.466B 0.00
Artivion (AORT) United States $0.966B 92.68
OPKO Health (OPK) United States $0.871B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.869B 16.91
Silk Road Medical (SILK) United States $0.855B 0.00
OrthoPediatrics (KIDS) United States $0.701B 0.00
Pulse Biosciences (PLSE) United States $0.654B 0.00
IRadimed (IRMD) United States $0.545B 30.52
SiBone (SIBN) United States $0.515B 0.00
Paragon 28 (FNA) United States $0.503B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.67
ORTHOFIX MEDICAL INC (OFIX) United States $0.472B 0.00
Pacific Biosciences Of California (PACB) United States $0.455B 0.00
Treace Medical Concepts (TMCI) United States $0.377B 0.00
Nevro (NVRO) United States $0.328B 0.00
AxoGen (AXGN) United States $0.324B 0.00
Sight Sciences (SGHT) United States $0.321B 0.00
Tactile Systems Technology (TCMD) United States $0.279B 9.54
Semler Scientific (SMLR) United States $0.273B 13.85
CVRx (CVRX) United States $0.237B 0.00
AngioDynamics (ANGO) United States $0.236B 0.00
Delcath Systems (DCTH) United States $0.215B 0.00
EDAP TMS S.A (EDAP) France $0.198B 0.00
908 Devices (MASS) United States $0.196B 0.00
NeuroPace (NPCE) United States $0.187B 0.00
Accuray (ARAY) United States $0.186B 0.00
Inogen (INGN) United States $0.171B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Atossa Genetics (ATOS) United States $0.145B 0.00
Yubo Biotech (YBGJ) China $0.128B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.086B 18.00
EnVVeno Medical (NVNO) United States $0.065B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
Neuronetics (STIM) United States $0.057B 0.00
SEP Acquisition (SEPA) United States $0.057B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.048B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
ReWalk Robotics (LFWD) Israel $0.038B 0.00
Lucid Diagnostics (LUCD) United States $0.037B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.023B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.022B 0.00
Aspira Women's Health (AWH) United States $0.022B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00